21 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CLNN

New
Clene
US$4.09-15.1%-56.9%US$37.2mUS$46.17PS77.5xE60.7%n/a

SPRY

New
ARS Pharmaceuticals
US$13.55-3.8%186.5%US$1.3bUS$26.50PS512.8xE69.8%n/a

CORT

Corcept Therapeutics
US$56.09-0.6%121.3%US$5.7bUS$74.90PE41.8xE41.0%n/a

BFRI

Biofrontera
US$0.78-6.4%-75.8%US$4.3mUS$11.50PS0.1xE72.2%n/a

PRPH

New
ProPhase Labs
US$0.77-0.6%-82.8%US$18.1mUS$18.50PS1.4xE77.4%0%

NRXP

NRx Pharmaceuticals
US$1.21-3.2%-59.4%US$13.1mUS$31.33PE-0.6xE74.1%n/a

ACER

Acer Therapeutics
US$0.80-5.4%-30.0%US$19.7mn/aPE-0.5xE66.2%n/a

TLSI

New
TriSalus Life Sciences
US$4.07-9.6%11.2%US$125.6mUS$11.92PS4.6xE66.7%n/a

BRTX

New
BioRestorative Therapies
US$1.40-9.1%-24.7%US$9.6mUS$13.00PS25.7xE61.8%n/a

KRYS

Krystal Biotech
US$178.10-3.3%74.6%US$5.1bUS$207.78PE97.8xE41.2%n/a

LQDA

Liquidia
US$10.12-1.5%50.6%US$859.9mUS$25.44PS54.9xE59.6%n/a

EVAX

Evaxion Biotech
US$1.40-20.5%-82.5%US$8.7mUS$11.56PS2.4xE69.9%n/a

PLX

Protalix BioTherapeutics
US$1.6936.3%19.9%US$119.9mUS$14.00PS2.7xE118.3%n/a

HROW

Harrow
US$42.44-18.1%361.8%US$1.4bUS$60.85PS8.9xE83.7%n/a

GALT

Galectin Therapeutics
US$2.82-2.9%38.7%US$172.9mUS$11.00PE-3.9xE62.3%n/a

IPA

ImmunoPrecise Antibodies
US$0.39-19.6%-70.8%US$11.8mUS$6.00PS0.6xE72.8%n/a

CDXC

ChromaDex
US$7.507.0%417.2%US$575.7mUS$7.96PE386.6xE81.8%n/a

OSTX

OS Therapies
US$1.73-31.5%n/aUS$37.0mUS$15.00PE-4.9xE-9.8%n/a

CSBR

Champions Oncology
US$4.32-6.1%-21.5%US$61.9mUS$6.00PS1.1xE146.9%n/a

BRKR

Bruker
US$53.37-4.6%-18.0%US$7.3bUS$74.74PE26.5xE32.3%0.4%

BTMD

biote
US$6.06-9.8%17.4%US$221.3mUS$9.54PE26.2xE64.8%n/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.